Associations between 25-hydroxy-vitamin D levels, lung function, and exacerbation outcomes in COPD: An analysis of the SPIROMICS cohort
Chest Jan 25, 2020
Burkes RM, Ceppe AS, Doerschuk CM, et al. - Researchers investigated the links between baseline 25-hydroxy-vitamin D (25-OH-vitamin D) and cross-sectional and longitudinal lung function and COPD exacerbations, by using the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS). Stored samples from 1,609 SPIROMICS participants with COPD were analyzed for serum 25-OH-vitamin D level. 25-OH-vitamin D concentrations were modeled continuously and divided as deficient (< 20 ng/ml) vs not deficient (≥ 20 ng/ml). Findings revealed worse cross-sectional and longitudinal lung function as well as increased odds of prior COPD exacerbations in relation to vitamin D deficiency. The potential usefulness of 25-OH-vitamin D levels was indicated as a marker of adverse COPD-related results.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries